Evidence map›Paper›PMID 42026608›Full record

ArticleBMC medical education2026

Teaching about dermatophytosis in the era of antifungal resistance: design, implementation, and evaluation of a multidisciplinary workshop in Honduras.

Bryan Ortiz, Alicia Moreno-Sabater, Fernando Perez, Asly Villeda Barahona, Sara Elvir, Kateryn Aguilar, Carmen Meza, Greisi Lopez, Gustavo Fontecha

Abstract read
In one paragraph

Article in BMC medical education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bryan OrtizInstitute for Microbiology Research, Faculty of Sciences, National Autonomous University of Honduras (UNAH), Tegucigalpa, Honduras. bryan.ortiz@unah.edu.hn.
Alicia Moreno-SabaterDepartment of Parasitology-Mycology, Saint-Antoine Hospital, Assistance Publique-H itaux de Paris (AP-HP), Paris, France.
Fernando PerezInstitute for Microbiology Research, Faculty of Sciences, National Autonomous University of Honduras (UNAH), Tegucigalpa, Honduras.
Asly Villeda BarahonaInstitute for Microbiology Research, Faculty of Sciences, National Autonomous University of Honduras (UNAH), Tegucigalpa, Honduras.
Sara ElvirInstitute for Microbiology Research, Faculty of Sciences, National Autonomous University of Honduras (UNAH), Tegucigalpa, Honduras.
Kateryn AguilarInstitute for Microbiology Research, Faculty of Sciences, National Autonomous University of Honduras (UNAH), Tegucigalpa, Honduras.
Carmen MezaPodyclinic, Diabetic Foot and Podiatry Clinic, Tegucigalpa, 11101, Honduras.
Greisi LopezPodyclinic, Diabetic Foot and Podiatry Clinic, Tegucigalpa, 11101, Honduras.
Gustavo FontechaInstitute for Microbiology Research, Faculty of Sciences, National Autonomous University of Honduras (UNAH), Tegucigalpa, Honduras.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global increase in fungal infections and the emergence of antifungal-resistant species, particularly Trichophyton indotineae, have exposed critical gaps in medical mycology training and diagnostic capacity, especially in low- and middle-income countries. Despite their high prevalence, dermatophytoses are underrepresented in health sciences curricula and continuing professional education, contributing to misdiagnosis, delayed treatment, and inappropriate antifungal use.

methodsWe designed, implemented, and evaluated a multidisciplinary educational workshop entitled “Medical Mycology: Dermatophytoses, New Challenges in the Era of Antifungal Resistance”, conducted in Honduras in September 2025. The 24-hour in-person intervention combined 16 h of theoretical instruction with 8 h of hands-on laboratory training and targeted healthcare professionals and laboratory personnel nationwide. Educational impact was assessed using pre- and post-intervention questionnaires evaluating knowledge on dermatophyte taxonomy, identification methods, epidemiology, and antifungal resistance. Additionally, a structured survey was applied to characterize participants’ institutional diagnostic capacities. Descriptive analyses were performed to compare pre- and post-workshop responses.

resultsAmong the 36 participants who completed both assessments, post-workshop results demonstrated substantial learning gains across all evaluated domains. The largest improvements were observed in recognition of recently revised dermatophyte genera and in understanding the transmission, clinical relevance, and terbinafine resistance mechanisms of T. indotineae. Correct response rates increased to near 100% for most items. The diagnostic capacity survey revealed that diagnostic practices in participating institutions are predominantly based on phenotypic methods, characterized by reliance on direct microscopy and culture, the exclusive use of morphological identification, and the absence of molecular methods, antifungal susceptibility testing, and MALDI-TOF mass spectrometry. The workshop also facilitated the development of standardized didactic materials and the establishment of a preliminary national network for future molecular surveillance.

conclusionsThis experience demonstrates that a structured, evidence-based educational intervention can significantly strengthen knowledge and practical skills in medical mycology. Such initiatives represent a scalable model to improve dermatophyte diagnosis and antifungal resistance awareness in resource-limited settings.

Indexed as

Antifungal AgentsDrug Resistance, FungalMycologyTineaCurriculumHondurasHumansAntifungal AgentsAntifungal resistance, Trichophyton indotineaeDermatophytosisMedical mycology education

Identifiers

PMID42026608
PMCPMC13238100

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.